Literature DB >> 28597252

Clinical practice guidelines of the French Association for Supportive Care in Cancer and the French Society for Psycho-oncology: refusal of treatment by adults afflicted with cancer.

J C Faivre1, V Adam2, V Block3, M Metzger4, J Salleron5, S Dauchy6,7.   

Abstract

PURPOSE: The study's purpose was to develop practical guidelines for assessment and management of refusal of treatment by adults afflicted with cancer.
METHODS: The French Association for Supportive Care in Cancer and the French Society for Psycho-oncology gathered a task force that applied a consensus methodology to draft guidelines studied predisposing situations, the diagnosis, regulatory aspects, and the management of refusal of treatment by adults afflicted with cancer.
RESULTS: We propose five guidelines: (1) be aware of the conditions/profiles of patients most often associated with refusal of treatment so as to adequately underpin the care and support measures; (2) understand the complexity of the process of refusal and knowing how to accurately identify the type and the modalities of the refused treatments; (3) apply a way to systematically analyze refusal, thereby promoting progression from a situation of disaccord toward a consensual decision; (4) devise procedures, according to the legal context, to address refusal of treatment that safeguards the stakeholders in situations of sustained disaccord; and (5) know the indications for ethical collective decision-making.
CONCLUSION: The quality of the relationship between patients and health professionals, and the communication between them are essential components involved in reaching a point of consent or refusal of treatment. A process of systematic analysis of refusal is recommended as the only way to ensure that all of the physiological, psychological, and contextual elements that are potentially involved are taken into account.

Entities:  

Keywords:  Decision-making; Guidelines; Health professional-patient relations/ethics; Neoplasms; Refusal of treatment; Review

Mesh:

Year:  2017        PMID: 28597252     DOI: 10.1007/s00520-017-3762-0

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  43 in total

1.  Refusal of postoperative radiotherapy and its association with survival in head and neck cancer.

Authors:  Zachary G Schwam; Zain Husain; Benjamin L Judson
Journal:  Radiother Oncol       Date:  2015-10-24       Impact factor: 6.280

2.  The Question of Clinical Equipoise and Patients' Best Interests.

Authors:  Spencer Phillips Hey; Robert D Truog
Journal:  AMA J Ethics       Date:  2015-12-01

Review 3.  Part 2: Patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing.

Authors:  Paul Hewitson; Joan Austoker
Journal:  BJU Int       Date:  2005-04       Impact factor: 5.588

4.  Treatment decision-making among older women with breast cancer.

Authors:  Desirée Ciambrone
Journal:  J Women Aging       Date:  2006

5.  Racial differences in treatment of early-stage prostate cancer.

Authors:  Kathryn E Richert-Boe; Sheila Weinmann; Jean A Shapiro; Benjamin A Rybicki; Shelley M Enger; Stephen K Van Den Eeden; Noel S Weiss
Journal:  Urology       Date:  2008-02-15       Impact factor: 2.649

Review 6.  A systematic review of factors influencing older adults' decision to accept or decline cancer treatment.

Authors:  Martine T E Puts; Brianne Tapscott; Margaret Fitch; Doris Howell; Johanne Monette; Doreen Wan-Chow-Wah; Monika Krzyzanowska; Nathasha B Leighl; Elena Springall; Shabbir M Alibhai
Journal:  Cancer Treat Rev       Date:  2014-12-26       Impact factor: 12.111

7.  The impact of inadequate knowledge on patient and spouse experience of prostate cancer.

Authors:  Andrea Docherty; Cannon Paul D Brothwell; Mary Symons
Journal:  Cancer Nurs       Date:  2007 Jan-Feb       Impact factor: 2.592

8.  Brachytherapy for prostate cancer: the patient's perspective.

Authors:  Peggy Ward-Smith
Journal:  Urol Nurs       Date:  2003-06

9.  Treatment decision making and its discontents.

Authors:  Chris Sinding; Jennifer Wiernikowski
Journal:  Soc Work Health Care       Date:  2009

10.  Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.

Authors:  B Joyce Davison; John L Oliffe; Tom Pickles; Lawrence Mroz
Journal:  Oncol Nurs Forum       Date:  2009-01       Impact factor: 2.172

View more
  2 in total

1.  Uveal Melanoma: Refusal of Treatment.

Authors:  Randy Christopher Bowen; Soto Hansell; Vishal Raval; Jacquelyn M Davanzo; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2021-08-27

Review 2.  Biomarkers of immunotherapy in non-small cell lung cancer.

Authors:  Lingling Wang; Yue Hu; Shengchao Wang; Jiali Shen; Xiaochen Wang
Journal:  Oncol Lett       Date:  2020-08-20       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.